Filgrastim
Links shared publicly online about this topic
Sandoz receives European Commission approval for biosimilar filgrastim
novartis.com — “Sandoz receives European Commission approval for biosimilar filgrastim” View full resource at novartis.com
Most Recently Shared on February 13, 2009 at 6:38 am By:
Sandoz receives European Commission approval for biosimilar filgrastim: http://twurl.nl/uafqtx
Sandoz receives positive EU opinion for biosimilar filgrastim
novartis.com — “Sandoz receives positive EU opinion for biosimilar filgrastim” View full resource at novartis.com
Most Recently Shared on November 21, 2008 at 12:17 pm By:
Sandoz receives positive EU opinion for biosimilar filgrastim : http://twurl.nl/4ntmsn
NMDP Phase III filgrastim trial: Biologics to provide pharmacy management services
news-medical.net — “Biologics, Inc., the leading cancer management company in the United States, announces that its Oncology Clinical Trial Services division has been selected by the National Marrow Donor Program® (NMDP), a nonprofit organization that facilitates unrelated hematopoietic cell transplants.” View full resource at news-medical.net
Most Recently Shared on February 12, 2010 at 7:37 am By:
Oncology News: NMDP Phase III filgrastim trial: Biologics to provide pharmacy management services: Biologics, Inc.... http://bit.ly/bXm2Qf
ingentaconnect Filgrastim/peginterferon--2a/ribavirin: Haematological disorders,...
ingentaconnect.com — “ingentaconnect Filgrastim/peginterferon--2a/ribavirin: Haematological disorders,...” View full resource at ingentaconnect.com
Most Recently Shared on February 1, 2011 at 3:34 am By:
Filgrastim/peginterferon--2a/ribavirin: Haematological disorders, psoriasis: case report: (Source: Reactions)Med... http://bit.ly/e73u6u
ingentaconnect Filgrastim/peginterferon/ribavirin: Agranulocytosis, psoriasis: c...
ingentaconnect.com — “ingentaconnect Filgrastim/peginterferon/ribavirin: Agranulocytosis, psoriasis: c...” View full resource at ingentaconnect.com
Most Recently Shared on December 21, 2010 at 6:35 pm By:
Filgrastim/peginterferon/ribavirin: Agranulocytosis, psoriasis: case report: (Source: Reactions)MedWorm Sponsor ... http://bit.ly/g7Xgux
Hospira Receives TGA Approval for Nivestim, Australia's First Biosimilar Filgrastim - Drugs.com MedNews
drugs.com — “Hospira, Inc. (NYSE HSP), the world leader in generic injectable pharmaceuticals, today announced that it has received Australian Therapeutic Goods Administrati” View full resource at drugs.com
Most Recently Shared on September 27, 2010 at 1:13 pm By:
Hospira Receives TGA Approval for Nivestim, Australia's First Biosimilar Filgrastim: -- Launch of Product Exp... http://bit.ly/c3ZCVu #drug
Nivestim(TM), A New Biosimilar Filgrastim, Is Approved In Europe For The Prevention Of Febrile Neutropenia Associated With Chemotherapy
medicalnewstoday.com — “Hospira announced that the EC has approved Nivestim(TM) (filgrastim) for the prevention of FN, the most serious haematological toxicity that occurs as a result of cancer chemotherapy(1). Nivestim” View full resource at medicalnewstoday.com
Most Recently Shared on June 15, 2010 at 1:05 pm By:
Nivestim(TM), A New Biosimilar Filgrastim, Is Approved In Europe For The Prevention Of Febrile Neutropenia Associated ... http://mnt.to/3DRJ
Use of Granulocyte Colony-Stimulating Factor in Patients With Severe Sepsis or Septic Shock - QualityPoint Technologies
qualitypointtech.net — “Does filgrastim or pegfilgrastim decrease mortality in patients with sepsis? American Journal of Health-System Pharmacy” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2010 at 11:00 am By:
Use of Granulocyte Colony-Stimulating Factor in Patients With Severe Sepsis or Septic Shock: Does filgrastim or pe... http://bit.ly/dBfVLk
Lenograstim reduces the incidence of febrile episo... [Leuk Res. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on December 8, 2010 at 1:32 pm By:
New Italian study: Lenograstim may reduce febrile episodes in patients undergoing transplant compared to filgrastim (http://bit.ly/dPVP6U).
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Novartis
We provide healthcare solutions that address the evolving needs of patients and societies worldwide.
-
Novartis
We provide healthcare solutions that address the evolving needs of patients and societies worldwide.
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
Advertisement

